Affimed NV (Affimed NV) Total Assets : $105.95 Mil (As of Dec. 2023)

View and export this data going back to 2014. Start your Free Trial

What is Affimed NV Total Assets?

Affimed NV's Total Assets for the quarter that ended in Dec. 2023 was $105.95 Mil.

During the past 12 months, Affimed NV's average Total Assets Growth Rate was 144.20% per year. During the past 3 years, the average Total Assets Growth Rate was -9.00% per year. During the past 5 years, the average Total Assets Growth Rate was 19.20% per year. During the past 10 years, the average Total Assets Growth Rate was 29.50% per year.

During the past 12 years, Affimed NV's highest 3-Year average Total Assets Growth Rate was 107.50%. The lowest was -9.00%. And the median was 13.40%.

Total Assets is connected with ROA %. Affimed NV's annualized ROA % for the quarter that ended in Dec. 2023 was -75.16%. Total Assets is also linked to Revenue through Asset Turnover. Affimed NV's Asset Turnover for the quarter that ended in Dec. 2023 was 0.00.

Affimed NV Total Assets Historical Data

The historical data trend for Affimed NV's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affimed NV Total Assets Chart

Affimed NV Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

124.84

213.78

254.39

212.41

105.95

Affimed NV Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Assets	Get a 7-Day Free Trial															212.41	179.83	145.95	128.56	105.95

Affimed NV Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Affimed NV's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	63.039	+	42.912
	=	105.95

Affimed NV's Total Assets for the quarter that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (Q: Dec. 2023 )	+	Total Liabilities (Q: Dec. 2023 )
	=	63.039	+	42.912
	=	105.95

Affimed NV (NAS:AFMD) Total Assets Explanation

Total Assets is connected with ROA %.

Affimed NV's annualized ROA % for the quarter that ended in Dec. 2023 is

ROA %	=	Net Income (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	-88.136	/	( (128.564	+	105.951)	/ 2 )
	=	-88.136	/	117.2575
	=	-75.16 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Affimed NV's Asset Turnover for the quarter that ended in Dec. 2023 is

	Asset Turnover
=	Revenue (Q: Dec. 2023 )	/	( (Total Assets (Q: Sep. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
=	0.45	/	( (128.564	+	105.951)	/ 2 )
=	0.45	/	117.2575
=	0.00

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Affimed NV Total Assets Related Terms

Thank you for viewing the detailed overview of Affimed NV's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Affimed NV (Affimed NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affimed NV (NAS:AFMD) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

A28:Germany

Address

Im Neuenheimer Feld 582, Technologiepark, Heidelberg, BW, DEU, 69120

Website

https://www.affimed.com

Affimed NV is a clinical-stage biopharmaceutical company. The company is engaged in discovering and developing targeted cancer immunotherapies. Its product candidates are being developed in the field of immuno-oncology, which represents an approach to cancer treatment that seeks to harness the body's immune defenses to fight tumor cells. The company is also developing single and combination therapies to treat cancers and other life-threatening diseases. Geographically, it derives a majority of revenue from the United States and also has a presence in Europe and Germany.